Avagacestat
Alternative Names: Amyloid beta modulator - Bristol-Myers Squibb; Aβ modulator - Bristol-Myers Squibb; BMS-708163Latest Information Update: 05 Nov 2023
At a glance
- Originator Bristol-Myers Squibb
- Class Antidementias
- Mechanism of Action Amyloid precursor protein secretase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease